PTCT icon

PTC Therapeutics
PTCT

Overview Fund Activity

211 hedge funds and large institutions have $3.94B invested in PTC Therapeutics in 2022 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 74 increasing their positions, 61 reducing their positions, and 17 closing their positions.

Holders
211
Holders Change
+32
Holders Change %
+17.88%
% of All Funds
3.65%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.14%
New
50
Increased
74
Reduced
61
Closed
17
Calls
$8.95M
Puts
$11.4M
Net Calls
-$2.45M
Net Calls Change
-$3.33M

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$209M
2
RI
2
RTW Investments
New York
$282M
3
WP
3
Woodline Partners
California
$39.2M
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$376M
5
Millennium Management
5
Millennium Management
New York
$22.2M

Top Sellers

1
State Street
1
State Street
Massachusetts
$142M
2
Franklin Resources
2
Franklin Resources
California
$224M
3
AC
3
Armistice Capital
New York
$146M
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$27.8M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$73.7M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$539M 10,731,144 +30,307 +0.3%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$376M 7,491,062 +457,557 +7%
Vanguard Group
3
Vanguard Group
Pennsylvania
$362M 7,211,720 +28,028 +0.4%
BlackRock
4
BlackRock
New York
$307M 6,108,417 +135,795 +2%
RI
5
RTW Investments
New York
$282M 5,620,580 +575,273 +11%
Franklin Resources
6
Franklin Resources
California
$224M 4,468,775 -443,035 -9%
Janus Henderson Group
7
Janus Henderson Group
United Kingdom
$209M 4,155,728 +2,020,052 +95%
AC
8
Armistice Capital
New York
$146M 2,900,000 -396,000 -12%
State Street
9
State Street
Massachusetts
$142M 2,823,232 -801,645 -22%
CCM
10
Camber Capital Management
Massachusetts
$123M 2,450,000 – –
Loomis, Sayles & Company
11
Loomis, Sayles & Company
Massachusetts
$81.3M 1,618,894 -17,941 -1%
Macquarie Group
12
Macquarie Group
Australia
$78.5M 1,562,218 -126,516 -7%
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$73.7M 1,467,193 -173,793 -11%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$64.2M 1,279,198 -54,321 -4%
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$52.9M 1,053,985 +101,198 +11%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$51M 1,015,294 -2,576 -0.3%
JPMorgan Chase & Co
17
JPMorgan Chase & Co
New York
$41.1M 818,719 -47,476 -5%
WP
18
Woodline Partners
California
$39.2M 780,537 +535,277 +218%
TCM
19
TimesSquare Capital Management
New York
$36.7M 731,890 +45,990 +7%
Norges Bank
20
Norges Bank
Norway
$34.7M 692,074 +11,146 +2%
Northern Trust
21
Northern Trust
Illinois
$32.5M 647,611 -7,958 -1%
Jacobs Levy Equity Management
22
Jacobs Levy Equity Management
New Jersey
$27.8M 552,863 -269,231 -33%
Charles Schwab
23
Charles Schwab
California
$27.5M 547,488 +18,950 +4%
Goldman Sachs
24
Goldman Sachs
New York
$25.4M 505,478 +9,298 +2%
Handelsbanken Fonder
25
Handelsbanken Fonder
Sweden
$25.4M 505,400 -15,000 -3%
1
2 3 4 5